PMID- 11303512
OWN - NLM
STAT- MEDLINE
DCOM- 20010614
LR  - 20190503
IS  - 1468-6244 (Electronic)
IS  - 0022-2593 (Print)
IS  - 0022-2593 (Linking)
VI  - 38
IP  - 3
DP  - 2001 Mar
TI  - Founder effect in multiple endocrine neoplasia type 1 (MEN 1) in Finland.
PG  - 185-9
FAU - Kytola, S
AU  - Kytola S
FAU - Villablanca, A
AU  - Villablanca A
FAU - Ebeling, T
AU  - Ebeling T
FAU - Nord, B
AU  - Nord B
FAU - Larsson, C
AU  - Larsson C
FAU - Hoog, A
AU  - Hoog A
FAU - Wong, F K
AU  - Wong FK
FAU - Valimaki, M
AU  - Valimaki M
FAU - Vierimaa, O
AU  - Vierimaa O
FAU - Teh, B T
AU  - Teh BT
FAU - Salmela, P I
AU  - Salmela PI
FAU - Leisti, J
AU  - Leisti J
LA  - eng
PT  - Letter
PT  - Research Support, Non-U.S. Gov't
PL  - England
TA  - J Med Genet
JT  - Journal of medical genetics
JID - 2985087R
RN  - 0 (MEN1 protein, human)
RN  - 0 (Neoplasm Proteins)
RN  - 0 (Proto-Oncogene Proteins)
RN  - 9007-49-2 (DNA)
SB  - IM
MH  - Chromosomes, Human, Pair 11/genetics
MH  - DNA/chemistry/genetics
MH  - DNA Mutational Analysis
MH  - Family Health
MH  - Female
MH  - Finland
MH  - *Founder Effect
MH  - Genotype
MH  - Haplotypes
MH  - Humans
MH  - Male
MH  - Microsatellite Repeats
MH  - Multiple Endocrine Neoplasia Type 1/*genetics/pathology
MH  - Mutation
MH  - Neoplasm Proteins/*genetics
MH  - Pedigree
MH  - *Proto-Oncogene Proteins
PMC - PMC1734833
EDAT- 2001/05/19 10:00
MHDA- 2001/06/23 10:01
PMCR- 2004/03/01
CRDT- 2001/05/19 10:00
PHST- 2001/05/19 10:00 [pubmed]
PHST- 2001/06/23 10:01 [medline]
PHST- 2001/05/19 10:00 [entrez]
PHST- 2004/03/01 00:00 [pmc-release]
AID - 10.1136/jmg.38.3.185 [doi]
PST - ppublish
SO  - J Med Genet. 2001 Mar;38(3):185-9. doi: 10.1136/jmg.38.3.185.